Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
Clinical trial NCT00676143 · TERMINATED
Trial details
- NCT number
- NCT00676143
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2012-10-01
- Enrollment
- 1100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.